The use of myocardial scintigraphy with thallium-199 for diagnosis of ischemic heart disease and assessment of efficacy of antianginal therapy

V. I. Chernov, V. F. Mordovin, S. V. Triss, N. A. Fedorova, E. Yu Kolomin, Zh V. Vesnina, A. Yu Fedorov, R. S. Karpov, Yu B. Lishmanov

Research output: Contribution to journalArticle

Abstract

The aim of the stidy was to investigate diagnostic value of myocardial scintigraphy with a new short living radionuclide 199TI for detection of myocardual ischemia and to elucidate the potential of this method for assessment of effects of calcium antagonists on myocardial perfusion in patients with ischemic heart disease. Myocardial scintigraphy was performed in 160 patients (105 patients with ischemic heart disease and 55 controls). In 51 patients scintigraphy was done before and after treatment with calcium antagonists. Myocardial scintigraphy with 199TI had high sentitivity (93%) and specificity (84%) for diagnosis of ischemic heart disease. Frequency of detection of perfusion defects directly depended on number of obstructed coronary arteries and on presence of postinfarction cardiosclerosis. Reduction of size of transient perfusion defects during treatment with calcium antagonists (isradipine, diltiazem, long acting verapamil) was observed in more that 50% of patients. Positive effect of these drugs on myocardial perfusion diminished with increase in number of obstructed vessels and in X-syndrome. In 20% of patients with ischemic heart disease therapy ith blockers of calcium channels was associated with expansion of zones of hypoperfusion without negative dynamics of clinical state. The latter fact made the use of myocardial perfusion scintigraphy especially important for the control of treatment with calcium anragonists.

Original languageEnglish
Pages (from-to)60-63
Number of pages4
JournalKardiologiya
Volume36
Issue number8
Publication statusPublished - 1996

Keywords

  • Calcium antagonists
  • Ischemic heart disease, radionuclide stidies
  • Myocardial perfusion
  • Myocardial scintigraphy
  • Thallium-199
  • X-syndrome

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'The use of myocardial scintigraphy with thallium-199 for diagnosis of ischemic heart disease and assessment of efficacy of antianginal therapy'. Together they form a unique fingerprint.

  • Cite this

    Chernov, V. I., Mordovin, V. F., Triss, S. V., Fedorova, N. A., Kolomin, E. Y., Vesnina, Z. V., Fedorov, A. Y., Karpov, R. S., & Lishmanov, Y. B. (1996). The use of myocardial scintigraphy with thallium-199 for diagnosis of ischemic heart disease and assessment of efficacy of antianginal therapy. Kardiologiya, 36(8), 60-63.